AGIOS PHARMACEUTICALS, INC. ($AGIO)
Filing Information
| Accession Number | 0001439222-26-000032 |
|---|---|
| Form Type | 4 |
| Filing Date | Mar 3, 2026 |
| Document | View SEC Filing |
Transactions
2
Total Shares
66,000
Total Value
$0.00
P&L
+inf% (+$1,838,760.00)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Corp Dev & Strategy | Restricted stock units | Derivative | Mar 1, 2026 | Grant/Award | 14,000 | $0.00 | $0.00 | 14,000 | Direct | โ | View Details | |
Chief Corp Dev & Strategy | Stock options (right to buy) | Derivative | Mar 1, 2026 | Grant/Award | 52,000 | $0.00 | $0.00 | 52,000 | Direct | โ | View Details |